Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 222.80
-5.76 (-2.52%)
At close: Dec 5, 2025
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 34.93 billion as of December 5, 2025. Its market cap has decreased by -2.05% in one year.
Market Cap
34.93B
Enterprise Value
54.20B
Revenue
27.59B
Ranking
n/a
PE Ratio
25.61
Stock Price
222.80
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 34.93B, a decrease of -38.52%. That is a compound annual growth rate of -5.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 34.93B | -17.63% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | 21.76B | 59.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 937.26B |
| Mankind Pharma | 910.34B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |